Immune-Related Adverse Events of the Gastrointestinal System
Cancers · 23.01.2023 · 15 (3) · 691
DOI: 10.3390/cancers15030691 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.01.2023. Verfasst von Steven Nicolaides und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Western Health, Melbourne, VIC 3011, Australia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICI) are a form of immunotherapy that have revolutionized the treatment of a number of cancers. Specifically, they are antibodies targeted against established and emerging immune checkpoints, such as cytotoxic T-cell antigen 4 (CTLA4), programmed cell death ligand 1 (PD-L1) and programmed cell death 1 protein (PD-1) on CD8-positive T cells, which promote the destruction of tumor cells. While the immune checkpoint inhibitors are very effective in the treatment of a number of cancers, their use is limited by serious and in some cases life-threatening immune-related adverse events. While these involve many organs, one of the most prevalent serious adverse events is immune checkpoint inhibitor colitis, occurring in a significant proportion of patients treated with this therapy. In this review, we aim to broadly describe the immune-related adverse events known to occur within the gastrointestinal system and the potential role played by the intestinal microbiome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Western Health, Melbourne, VIC 3011, Australia.
- Department of Gastroenterology, The Alfred, Melbourne, VIC 3004, Australia.
- Department of Medicine, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
- Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC 3050, Australia.
Zitieren
APA
Nicolaides, S., & Boussioutas, A. (2023). Immune-Related Adverse Events of the Gastrointestinal System. Cancers, 15(3), 691. https://doi.org/10.3390/cancers15030691
Vancouver
Nicolaides S, Boussioutas A. Immune-Related Adverse Events of the Gastrointestinal System. Cancers. 2023;15(3):691. doi:10.3390/cancers15030691
BibTeX
@article{Nicolaides2023,
author = {Nicolaides, Steven and Boussioutas, Alex},
title = {Immune-Related Adverse Events of the Gastrointestinal System},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {691},
doi = {10.3390/cancers15030691}
}
EUVIMED